Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01179555 · ClinicalTrials.gov registry record · NA
Confronting Unequal Eye Care in Pennsylvania
A NA study, sponsored by Wills Eye.
- Completed
- Registry status
- NA
- Development phase
- 206
- Enrollment target
NCT01179555 is a NA study that has completed, run by Wills Eye. The registered enrollment target is 206 participants.
The verdict
NCT01179555, a NA study, has completed, sponsored by Wills Eye.
- COMPLETED
- Registry status
- NA
- Development phase
- 206 participants
- Enrollment target
Study Summary
Pt. 1 Diabetic retinopathy is a common eye condition among diabetic adults and can lead to severe vision impairment and even blindness. African Americans are more likely to have vision loss from diabetic retinopathy due to a variety of factors, including cultural barriers to care. The investigators aim to increase the rates of eye exams in diabetic African American adults by providing culturally relevant home-based interventions. These interventions will increase the knowledge about diabetes and the eyes and the awareness of ocular risks due to diabetes. 206 African American adults, over the age of 65, with diabetes will be recruited from primary care clinics at Thomas Jefferson and Temple University. Eligible patients who consent to participate will have baseline information taken about medical and ocular history, understanding of diabetes and a hemoglobin A1C level obtained. The subjects will then be randomized to one of two treatment conditions: Behavioral Activation or Supportive Therapy, each of which will be delivered over 4 sessions. Behavioral Activation will consist of educational materials, referral assistance for eye clinics, and addressing patient specific barriers to care. Supportive Therapy will consist of supportive but non-directional interaction with the patient exploring the impact of aging and diabetes on the patient's life. The investigators hypothesize that more patients who receive Behavioral Activation will have a dilated fundus exam (the primary outcome variable), understand the risks of diabetic complications and feel less depression then subjects who receive Supportive Therapy.
Interventions
- BEHAVIORAL Supportive Therapy
- BEHAVIORAL Behavioral Activation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 206 participants |
| Start Date | 2010-10 |
| Est. Completion | 2014-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01179555
The ClinicalTrials.gov registry entry for NCT01179555 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 206 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wills Eye, which has 59 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Supportive Therapy is the first listed.
NCT01179555 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01179555 about?
NCT01179555 is a clinical study titled "Confronting Unequal Eye Care in Pennsylvania". Pt. 1 Diabetic retinopathy is a common eye condition among diabetic adults and can lead to severe vision impairment and even blindness. African Americans are more likely to have vision loss from diabetic retinopathy due to a variety of factors, including cultural barriers to care. The investigators ...
What is the current status of trial NCT01179555?
This trial is currently completed. It is a NA study. The enrollment target is 206 participants. The study started on 2010-10. Estimated completion is 2014-05.
What interventions are being tested in trial NCT01179555?
The interventions under investigation include: Supportive Therapy (BEHAVIORAL), Behavioral Activation (BEHAVIORAL).
Who is sponsoring clinical trial NCT01179555?
This trial is sponsored by Wills Eye, which has 59 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.